DME Capital Management, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Coya Therapeutics, Inc. Common Stock, par value $0.0001 per share (COYA)

Filing Manager
DME Capital Management, LP
Reporting Manager
DME Advisors GP, L.L.C.
Security
Coya Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
COYA
Shares outstanding
16,681,212 shares
Disclosed Ownership
1,651,440 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:26:38 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"DME Capital Management, LP disclosed 9.9% ownership in Coya Therapeutics, Inc. Common Stock, par value $0.0001 per share (COYA) on 31 Dec 2024."

Quick Takeaways

  • DME Capital Management, LP filed SCHEDULE 13G/A for Coya Therapeutics, Inc. Common Stock, par value $0.0001 per share (COYA).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:26.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
DME Capital Management, LP 7.6% 1,267,669 0 1,267,669 /s/ Daniel Roitman DME Advisors GP, LLC, its General Partner, by Daniel Roitman/Chief Operating Officer
DME Advisors, LP 2.3% 383,771 0 383,771 /s/ Daniel Roitman DME Advisors GP, LLC, its General Partner, by Daniel Roitman/Chief Operating Officer
DME Advisors GP, L.L.C. 9.9% 1,651,440 0 1,651,440 /s/ Daniel Roitman Daniel Roitman/Chief Operating Officer
EINHORN DAVID 9.9% 1,651,440 0 1,651,440 /s/ Daniel Roitman* Daniel Roitman, on behalf of David Einhorn
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .